Reid Laurence

CIK: 0001492749
Director

Reid Laurence is a corporate insider at ALNYLAM PHARMACEUTICALS, INC. (ALNY) filing SEC Form 4 transactions. 64 transactions across 4 companies, totaling $86,398 in purchases and $5,224,925 in sales. Source: SEC EDGAR.

Total Transactions
64
Total Buy Value
$86K
Total Sell Value
$5.22M
Net Activity
$-5.14M
Last Transaction
Sep 2025
Companies
4

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Award
Shares
17,400
Price
$1.23
Value
$21K
Type
Award
Shares
42,000
Price
-
Value
-
Type
Award
Shares
17,000
Price
-
Value
-
Decibel Therapeutics, Inc.
DBTX
Type
Disposition
Shares
1,072,539
Price
-
Value
-
Decibel Therapeutics, Inc.
DBTX
Type
Disposition
Shares
72,000
Price
-
Value
-
Decibel Therapeutics, Inc.
DBTX
Type
Disposition
Shares
187,500
Price
-
Value
-
Decibel Therapeutics, Inc.
DBTX
Type
Disposition
Shares
220,849
Price
-
Value
-
Decibel Therapeutics, Inc.
DBTX
Type
Award
Shares
72,000
Price
$0.00
Value
$0
Decibel Therapeutics, Inc.
DBTX
Type
Award
Shares
195,000
Price
$0.00
Value
$0
Decibel Therapeutics, Inc.
DBTX
Type
Award
Shares
187,500
Price
$0.00
Value
$0
Decibel Therapeutics, Inc.
DBTX
Type
Purchase
Shares
10,000
Price
$7.64
Value
$76K
Type
Exercise
Shares
17,000
Price
$0.00
Value
$0
Type
Tax Payment
Shares
2,802
Price
$97.00
Value
$272K
Type
Exercise
Shares
17,000
Price
$15.99
Value
$272K
Type
Award
Shares
6,667
Price
$0.00
Value
$0
Type
Exercise
Shares
3,639
Price
$0.00
Value
$0
Type
Exercise
Shares
3,861
Price
$0.00
Value
$0
Type
Exercise
Shares
2,500
Price
$0.00
Value
$0
Type
Sale
Shares
102
Price
$91.79
Value
$9K
Type
Sale
Shares
4,485
Price
$91.08
Value
$408K